Trial intelligence / Profile preview

Lansoprazole in Isolated Chronic Post Nasal Drip

NCT00335283Phase 3Completed

Sponsor
Vanderbilt University
Start
Aug 2006
Primary completion
Dec 2008
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of lansoprazole in post-nasal drip (PND), sponsored by Vanderbilt University. Started Aug 2006; status: completed.

02

Drugs

lansoprazole
03

Conditions

post-nasal drip (PND)

Beyond the preview

Go deeper on NCT00335283.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00335283.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call